186 related articles for article (PubMed ID: 10886579)
21. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
23. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis.
Gerakis A; Hadjidakis D; Kokkinakis E; Apostolou T; Raptis S; Billis A
J Nephrol; 2000; 13(6):437-43. PubMed ID: 11132760
[TBL] [Abstract][Full Text] [Related]
24. Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel.
Haenggi W; Casez JP; Birkhaeuser MH; Lippuner K; Jaeger P
Osteoporos Int; 1994 Mar; 4(2):99-103. PubMed ID: 8003848
[TBL] [Abstract][Full Text] [Related]
25. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
26. Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women.
Ohta H; Sugimoto I; Masuda A; Komukai S; Suda Y; Makita K; Takamatsu K; Horiguchi F; Nozawa S
Bone; 1996 Mar; 18(3):227-31. PubMed ID: 8703577
[TBL] [Abstract][Full Text] [Related]
27. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
28. [The profile of low bone mass in amenorrhea with elevated follicle stimulating hormone].
Yu Q; Lin S; He F
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):78-81. PubMed ID: 11263202
[TBL] [Abstract][Full Text] [Related]
29. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
[TBL] [Abstract][Full Text] [Related]
30. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
Inaba M; Nagasue K; Okuno S; Ueda M; Kumeda Y; Imanishi Y; Shoji T; Ishimura E; Ohta T; Nakatani T; Kim M; Nishizawa Y
Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
[TBL] [Abstract][Full Text] [Related]
33. Bone density at multiple skeletal sites in amenorrheic athletes.
Rencken ML; Chesnut CH; Drinkwater BL
JAMA; 1996 Jul; 276(3):238-40. PubMed ID: 8667570
[TBL] [Abstract][Full Text] [Related]
34. [Hormonal activity of the hypophysial-gonadal axis versus the mineral bone density and specific markers of bone turnover in haemodialysis population].
Kurnatowska I; Zygmunt A; Fijałkowska-Morawska J; Białkowska J; Jabłkowski M; Nowicki M; Lewiński A
Pol Merkur Lekarski; 2006 Apr; 20(118):408-12. PubMed ID: 16886562
[TBL] [Abstract][Full Text] [Related]
35. Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Haghverdi F; Farbodara T; Mortaji S; Soltani P; Saidi N
Iran J Kidney Dis; 2014 Nov; 8(6):461-6. PubMed ID: 25362221
[TBL] [Abstract][Full Text] [Related]
36. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of osteopenia among adolescent girls with oligo/amenorrhea.
Csermely T; Halvax L; Schmidt E; Zámbó K; Vadon G; Szabó I; Szilágyi A
Gynecol Endocrinol; 2002 Apr; 16(2):99-105. PubMed ID: 12012630
[TBL] [Abstract][Full Text] [Related]
39. Low bone mineral density at axial and appendicular sites in amenorrheic athletes.
Myburgh KH; Bachrach LK; Lewis B; Kent K; Marcus R
Med Sci Sports Exerc; 1993 Nov; 25(11):1197-202. PubMed ID: 8289605
[TBL] [Abstract][Full Text] [Related]
40. Sex hormones in amenorrheic women with alcoholic liver disease.
Välimäki M; Pelkonen R; Salaspuro M; Härkönen M; Hirvonen E; Ylikahri R
J Clin Endocrinol Metab; 1984 Jul; 59(1):133-8. PubMed ID: 6427268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
